Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

MYSTERIOUS: 9 - You Need To See This

Bird flu vaccines face a problem: eggs

Fertilized hen eggs are still the main ingredient in making vaccines that may protect us against H5N1

Salon

Scientists are testing mRNA vaccines to protect cows and people against bird flu

The bird flu outbreak in U.S. dairy cows is prompting development of new, next-generation mRNA vaccines — akin to the shots deployed during the COVID-19 pandemic

The Independent UK

Is This Biotech Stock's OpenAI Partnership a Game-Changer?

With AI making waves in biotech, could this biotech’s OpenAI partnership be the catalyst for new highs?

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Novavax strikes $1.2 billion deal with Sanofi in major turnaround

It's a major turnaround for a drug company that warned last year about its ability to stay in business.

Axios

Coroner probes vaccine link to young woman's death

A Victorian coroner is investigating whether a woman's death from heart inflammation after receiving her third COVID-19 jab was due to the Moderna vaccine.

AAP

Biotech Investors: Should You Buy, Hold, or Sell Moderna (MRNA) and Arrowhead Pharmaceuticals (ARWR)?

Despite facing several challenges, the biotech sector thrives due to growing demand for effective treatments, consistent innovations, and a sustained demand for high-quality drugs and therapies. Let's assess whether one should Buy, Hold, or Sell biotech stocks Moderna (MRNA) and Arrowhead Pharmaceuticals (ARWR). Keep reading.

StockNews.com

Covid vaccines cut risk of virus-related heart failure and blood clots, study finds

Researchers say jabs substantially reduce for up to a year the chances of serious cardiovascular complications

The Guardian - UK

Read news from The Economist, FT, and more,
with one subscription

Stocks Close Mildly Lower on Caution Ahead of Tuesday’s U.S. CPI Report

The S&P 500 Index ($SPX ) (SPY ) on Monday closed down -0.11%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.12%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed -0.37%. Stocks Monday traded mildly lower on a +2.3 bp rise in the 10-year T-note...

Barchart

Moderna (MRNA) Earnings Analysis: Buy or Watch for Gains?

Moderna’s (MRNA) mRNA platform is positioned to deliver significant long-term impact with its mRNA medicines, but declining sales amid plummeting demand for its COVID-19 vaccine, steep losses, and cash burn reflect uncertainty around its near-term prospects. As MRNA is set to release its fourth-quarter 2023 results this Thursday, let’s find…

StockNews.com

Moderna (MRNA) and Biogen (BIIB) - Are There Upsides Left in These Biotech Stocks?

Despite macroeconomic challenges, the biotech industry thrives on innovation, demand, adaptability, and technological advancements, demonstrating resilience. So, let’s analyze the upside potential of popular biotech stocks Biogen (BIIB) and Moderna (MRNA).

StockNews.com

New mRNA 'cancer vaccine' trial launches in UK

The first U.K. patient has received a dose of "cancer vaccine" in a new trial.

LiveScience

Moderna (MRNA) vs. Exelixis (EXEL) - Which Biotech Stock Is Worth Buying?

The biotech industry is poised for long-term growth, supported by the advancements in personalized medicine and integration with information technology. While leading biotech stocks Moderna (MRNA) and Exelixis (EXEL) should benefit from the industry tailwinds, let us predict which stock is worth buying.

StockNews.com

‘Medicine is going personalised’: Moderna’s UK boss on the coming vaccine revolution

Darius Hughes was a key figure in Pfizer’s pioneering Covid vaccine drive. Now he has changed companies – and sees a big future for mRNA technology

The Guardian - UK

A Biochemist Reveals The One Tech That Could Revolutionize Drug Discovery

How mRNA-based drugs interact with the immune system and how they are degraded in human cells can help lead to safe, durable, and effective treatments.

Inverse

Get all your
news in one place.

100's of premium titles.
One news app.

Top News

Moderna's COVID Vaccine Sales Exceed Expectations in 2023!

In a stunning achievement, Moderna recently announced that their preliminary COVID vaccine sales for 2023 have met their target. This is fantastic news for...

Top News

Florida Surgeon General's Claims on COVID Vaccines Debunked as Nonsense

Explore the debunked claims made by the Florida State Surgeon General regarding COVID vaccines and the integration of contaminants into DNA in this insight...

The Conversation

Drugs of the future will be easier and faster to make, thanks to mRNA – after researchers work out a few remaining kinks

Vaccines have been reliably and affordably protecting people from diseases worldwide for centuries. Until the COVID-19 pandemic, however, vaccine development was still a long and idiosyncratic process. Traditionally, researchers had to tailor manufacturing processes and facilities for each vaccine candidate, and the scientific knowledge gained from one vaccine was often…

The Independent UK

Covid jabs could be sold on the high street like flu vaccine

Boots and Superdrug have confirmed they are looking at ways to sell Covid vaccines from their high street stores

Get all your
news in one place.

100's of premium titles.
One news app.

Top News

FDA Spots Control Irregularities in Moderna's US Plant

Dive into the intriguing saga of unanticipated control failures at Moderna's magnate production plant, a juicy scoop exclusively unraveled by the meticulou...

Latin Times

Moderna CEO Says Melanoma Vaccine Could Be Available By 2025

Globally there were an estimated 325,000 new melanoma cases and 57 ,000 deaths from the disease in 2020.

Top News

Moderna Tests Promising Personalized Skin Cancer Vaccine with 49% Improvement!

Moderna tests a novel approach to battle skin cancer, with a vaccine showing benefits for melanoma patients. Treatment could be available by 2025.

Barchart

Stocks and Bonds Continue Higher on Dovish Fed and Improved Soft-Landing Prospects

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is up +0.41%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.29%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.17%. Stocks this morning are mildly higher, with the S&P...

International Business Times

Moderna CEO Says Melanoma Vaccine Could Be Available By 2025

Moderna CEO Stephane Bancel told AFP his company's experimental vaccine against melanoma could be available in as little as two years, in what would amount to a landmark step against the most serious form of skin cancer.

The Conversation

Customizing mRNA is easy, and that's what makes it the next frontier for personalized medicine − a molecular biologist explains

While using mRNA as medicine is new, mRNA has been inside you for your entire life. The cells in your body create mRNAs that serve as instructions to make specific proteins you need to function. Researchers can create new mRNAs to correct those instructions when they aren’t working.

Kiplinger

Should You Invest In IPOs? It's Still A Risky Prospect

Investing in IPOs may sound exciting, but it's often better to wait for newly public stocks to mature before buying.

1 … 8 9 10 11

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Dow Jones Industrials

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.